Literature DB >> 27009935

Benign and Malignant Breast Disease at Rwanda's First Public Cancer Referral Center.

Lydia E Pace1, Jean-Marie V Dusengimana2, Vedaste Hategekimana3, Hamissy Habineza2, Jean Bosco Bigirimana2, Neo Tapela4, Cadet Mutumbira3, Egide Mpanumusingo3, Jane E Brock5, Emily Meserve5, Alain Uwumugambi3, Deborah Dillon5, Nancy L Keating5, Lawrence N Shulman6, Tharcisse Mpunga3.   

Abstract

BACKGROUND: Breast cancer incidence is rising in low- and middle-income countries. Understanding the distribution of breast disease seen in clinical practice in such settings can guide early detection efforts and clinical algorithms, as well as support future monitoring of cancer detection rates and stage. PATIENTS AND METHODS: We conducted a retrospective medical record review of 353 patients who presented to Butaro Cancer Center of Excellence in Rwanda with an undiagnosed breast concern during the first 18 months of the cancer program.
RESULTS: Eighty-two percent of patients presented with a breast mass. Of these, 55% were diagnosed with breast cancer and 36% were diagnosed with benign disease. Cancer rates were highest among women 50 years and older. Among all patients diagnosed with breast cancer, 20% had stage I or II disease at diagnosis, 46% had locally advanced (stage III) disease, and 31% had metastatic disease.
CONCLUSION: After the launch of Rwanda's first public cancer referral center and breast clinic, cancer detection rates were high among patients presenting with an undiagnosed breast concern. These findings will provide initial data to allow monitoring of changes in the distribution of benign and malignant disease and of cancer stage as cancer awareness and services expand nationally. IMPLICATIONS FOR PRACTICE: The numbers of cases and deaths from breast cancer are rising in low-income countries. In many of these settings, health care systems to address breast problems and efficiently refer patients with symptoms concerning for cancer are rudimentary. Understanding the distribution of breast disease seen in such settings can guide early detection efforts and clinical algorithms. This study describes the characteristics of patients who came with a breast concern to Rwanda's first public cancer referral center during its first 18 months. More than half of patients with a breast mass were diagnosed with cancer; most had late-stage disease. Monitoring changes in the types of breast disease and cancer stages seen in Rwanda will be critical as breast cancer awareness and services grow. ©AlphaMed Press.

Entities:  

Keywords:  Africa; Benign breast disease; Breast cancer; Rwanda

Mesh:

Year:  2016        PMID: 27009935      PMCID: PMC4861361          DOI: 10.1634/theoncologist.2015-0388

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  22 in total

1.  Pattern of breast masses in Lagos: a private health facility review of 189 consecutive patients.

Authors:  E A Jeje; B O Mofikoya; Y E Oku
Journal:  Nig Q J Hosp Med       Date:  2010 Jan-Mar

2.  80 under 40 by 2020: an equity agenda for NCDs and injuries.

Authors:  Agnes Binagwaho; Marie Aimée Muhimpundu; Gene Bukhman
Journal:  Lancet       Date:  2014-01-04       Impact factor: 79.321

Review 3.  Challenges to the early diagnosis and treatment of breast cancer in developing countries.

Authors:  Karla Unger-Saldaña
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Spectrum of complaints presented at a specialist breast clinic in kumasi, ghana.

Authors:  M Ohene-Yeboah; Ep Amaning
Journal:  Ghana Med J       Date:  2008-09

5.  Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study.

Authors:  Dafalla Omer Abuidris; Ahmed Elsheikh; Majdeldien Ali; Hassan Musa; Elgaili Elgaili; Anas O Ahmed; Imadeldien Sulieman; Sulma Ibrahim Mohammed
Journal:  Lancet Oncol       Date:  2013-01-31       Impact factor: 41.316

Review 6.  Evaluation of abnormal mammography results and palpable breast abnormalities.

Authors:  Karla Kerlikowske; Rebecca Smith-Bindman; Britt-Marie Ljung; Deborah Grady
Journal:  Ann Intern Med       Date:  2003-08-19       Impact factor: 25.391

7.  Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation.

Authors:  Cheng-Har Yip; Robert A Smith; Benjamin O Anderson; Anthony B Miller; David B Thomas; Eng-Suan Ang; Rosemary S Caffarella; Marilys Corbex; Gary L Kreps; Anne McTiernan
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

8.  Breast cancer in developing countries: opportunities for improved survival.

Authors:  Lawrence N Shulman; Walter Willett; Amy Sievers; Felicia M Knaul
Journal:  J Oncol       Date:  2010-12-29       Impact factor: 4.375

9.  Breast lumps: a 21-year single-center clinical and histological analysis.

Authors:  Gabriel E Njeze
Journal:  Niger J Surg       Date:  2014-01

Review 10.  Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis.

Authors:  Amanda Eng; Valerie McCormack; Isabel dos-Santos-Silva
Journal:  PLoS Med       Date:  2014-09-09       Impact factor: 11.069

View more
  19 in total

1.  Cancer du sein chez les Rwandaises en âge de procréer du district sud de Kayonza : facteurs influençant les pratiques de dépistage.

Authors:  Pierre Céléstin Igiraneza; Lilian A Omondi; Bellancille Nikuze; Marie Goretti Uwayezu; Margaret Fitch; Gaudence Niyonsenga
Journal:  Can Oncol Nurs J       Date:  2021-07-01

2.  Factors influencing breast cancer screening practices among women of reproductive age in South Kayonza District, Rwanda.

Authors:  Pierre Céléstin Igiraneza; Lilian A Omondi; Bellancille Nikuze; Marie Goretti Uwayezu; Margaret Fitch; Gaudence Niyonsenga
Journal:  Can Oncol Nurs J       Date:  2021-07-01

Review 3.  Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.

Authors:  Lydia E Pace; Lawrence N Shulman
Journal:  Oncologist       Date:  2016-04-18

Review 4.  Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge.

Authors:  Yehoda M Martei; Lydia E Pace; Jane E Brock; Lawrence N Shulman
Journal:  Clin Lab Med       Date:  2017-12-13       Impact factor: 1.935

5.  Psychometric Properties of the Beck Depression Inventory (BDI-II) in Cancer Patients: Cancer Patients from Butaro Ambulatory Cancer Center, Rwanda.

Authors:  Emmanuel Biracyaza; Samuel Habimana; Donat Rusengamihigo
Journal:  Psychol Res Behav Manag       Date:  2021-06-02

Review 6.  Breast cancer in sub-Saharan Africa: The current state and uncertain future.

Authors:  Claudia A Anyigba; Gordon A Awandare; Lily Paemka
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

7.  Characterizing breast conditions at an open-access breast clinic in South Africa: a model that is more than cancer care for a resource-limited setting.

Authors:  Sarah Rayne; Naomi Lince-Deroche; Cheryl Hendrickson; Kate Shearer; Faith Moyo; Pam Michelow; Grace Rubin; Carol Benn; Cynthia Firnhaber
Journal:  BMC Health Serv Res       Date:  2017-01-21       Impact factor: 2.655

8.  Demonstration of an algorithm to overcome health system-related barriers to timely diagnosis of breast diseases in rural Zambia.

Authors:  Leeya F Pinder; Jean-Baptiste Nzayisenga; Aaron Shibemba; Victor Kusweje; Hector Chiboola; Mary Amuyunzu-Nyamongo; Sharon Kapambwe; Catherine Mwaba; Pavlo Lermontov; Chibamba Mumba; Ronda Henry-Tillman; Groesbeck P Parham
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

Review 9.  Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis.

Authors:  Davies Adeloye; Olaperi Y Sowunmi; Wura Jacobs; Rotimi A David; Adeyemi A Adeosun; Ann O Amuta; Sanjay Misra; Muktar Gadanya; Asa Auta; Michael O Harhay; Kit Yee Chan
Journal:  J Glob Health       Date:  2018-06       Impact factor: 4.413

10.  Age distribution and types of breast lesions among Afghan women diagnosed by fine needle aspiration cytology (FNAC) at a tertiary care centre in Afghanistan: a descriptive cross-sectional study.

Authors:  Ramin Saadaat; Jamshid Abdul-Ghafar; Ahmed Maseh Haidary; Soma Rahmani; Nooria Atta
Journal:  BMJ Open       Date:  2020-09-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.